Maternal-fetal in vivo imaging: A combined PET and MRI study

Journal of Nuclear Medicine

Volumn 44, Issue 9, 2003, Pages 1522-1530

  Benveniste, Helene ^a,b   Fowler, Joanna S ^a   Rooney, William D ^a   Moller, Daryn H ^b   Backus, W Walter ^b   Warner, Donald A ^a   Carter, Pauline ^a   King, Payton ^a   Scharf, Bruce ^a,c   Alexoff, David A ^a   Ma, Yeming ^a   Vaska, Paul ^a   Schlyer, David ^a   Volkow, Nora D ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Imaging; In vivo; Maternal fetal exchange; Primate

Indexed keywords

FLUORODEOXYGLUCOSE F 18; ISOTOPE; PROPOFOL; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ARTICLE; BIOACCUMULATION; BLADDER; BODY WEIGHT; BRAIN; CALCULATION; CLINICAL PROTOCOL; COMPUTER PROGRAM; CONTROLLED STUDY; DELIVERY; FEMALE; FETUS; FETUS DEVELOPMENT; GENERAL ANESTHESIA; GESTATION PERIOD; HEALTH STATUS; HEART; IMAGING; IN VIVO STUDY; INSTRUMENT; MOTHER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACENTA; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; PRIMATE; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; STANDARDIZATION; TIME; WHOLE BODY RADIATION; ANIMAL; ANTIBODY SPECIFICITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EVALUATION; FEASIBILITY STUDY; FETOMATERNAL TRANSFUSION; HISTOLOGY; IMAGE SUBTRACTION; MACACA; METABOLISM; METHODOLOGY; SCINTISCANNING; THREE DIMENSIONAL IMAGING; TISSUE DISTRIBUTION;

ANIMALS; FEASIBILITY STUDIES; FEMALE; FETUS; FLUORODEOXYGLUCOSE F18; IMAGING, THREE-DIMENSIONAL; MACACA RADIATA; MAGNETIC RESONANCE IMAGING; MATERNAL-FETAL EXCHANGE; ORGAN SPECIFICITY; PLACENTA; PREGNANCY; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0142181254     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Dyer NC, Brill AB, Raye J, Gutberle R, Stahlman M. Maternal-fetal exchange of Fe-59: radiation-dosimetry and biokinetics in human and sheep studies. Radiat Res. 1973;53:488-495.
2. Rosso P Nutrition and maternal-fetal exchange. Am J Clin Nutr. 1981;34:744-755.
3. Lepage P, Vandeperre P, Msellati P, et al. Mother-to-child transmission of human-immunodeficiency-virus type-1 (HIV-1) and its determinants: a cohort study in Kigali, Rwanda. Am J Epidemiol 1993;137:589-599.
4. Tuntland T, Odinecs A, Pereira CM, Nosbisch C, Unadkat JD In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus. Am J Obstet Gynecol. 1999;180:198-206.
5. Chamberlain G. Placental transfer of drugs Clin Exp Obstet Gynecol 1986;13: 107-112.
6. Sastry BVR. Techniques to study human placental transport. Adv Drug Deliv Rev. 1999;38:17-39
7. Jansson T, Powell TL. Placental nutrient transfer and fetal growth Nutrition. 2000;16:500-502.
8. Dalteno SL Cannabinoid exposure: effects on development. Neurobehav Toxicol Teratol. 1986;8:345-352.
9. Krug SE Cocaine abuse: historical, epidemiologic, and clinical perspectives for pediatricians. Adv Pediatr 1989;36:369-406.
10. Levy M, Koren G. Obstetric and neonatal effects of drugs of abuse. Emerg Med Clin North Am. 1990;8:633-652.
11. Schenker S, Yang YQ, Johnson RF, et al. The transfer of cocaine and its metabolites across the term human placenta. Clin Pharmacol Ther. 1993;53:329-339
12. Ganapathy V, Prasad PD, Ganapathy ME, Leibach FH. Placental transporters relevant to drug distribution across the maternal-fetal interface J Pharmacol Exp Ther. 2000;294:413-420.
13. Kan RE, Hughes SC, Rosen MA, Kessin C, Preston PG, Lobo EP. Intravenous remifentanil: placental transfer, maternal and neonatal effects. Anesthesiology. 1998;88:1467-1474.
14. Hostetter A, Ritchie JC, Stowe ZN. Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol Psychiatry. 2000;48: 1032-1034.
15. Brace RA. Physiology of amniotic fluid volume regulation. Clin Obstet Gynecol. 1997;40:280-289
16. Patterson TA, Binienda ZK, Lipe GW, Gillam MP, Slikker W Jr, Sandberg JA. Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion. Drug Metab Dispos. 1997;25:453-459.
17. Nicklas AH, Baker ME. Imaging strategies in the pregnant cancer patient. Semin Oncol. 2000;27:623-632.
18. 11C-Methionine kinetics in pregnant rhesus monkeys studied by positron emission tomography: a new approach to fetomaternal metabolism Acta Obstret Gynecol Scand 1984;63:641-645.
19. Hartvig P, Lindberg BS, Lilja A, Lundqvist H, Langstrom B, Rane A. Positron emission tomography in studies on fetomaternal disposition of opioids. Dev Pharmacol Ther. 1989;12:74-80.
20. 18F]fluoro-2-deoxy-2-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986;27:235-238.
21. Garden AS, Roberts N. Fetal and fetal organ volume estimations with magnetic resonance imaging. Am J Obstet Gynecol. 1996;175:442-448.
22. Garel C, Chantrel E, Brisse H, et al. Fetal cerebral cortex: normal gestational landmarks identified using prenatal MR imaging. AJNR. 2001;22:184-189.
23. Levine D, Trap I, Mehta TS, Barnes PD. MR imaging appearance of fetal cerebral ventricular morphology. Radiology. 2002;223:652-660.
24. Sanchez-Alcaraz A, Quintana MB, Laguarda M. Placental transfer and neonatal effects of propofol in caesarean section. J Clin Pharm Ther 1998;23:19-23.
25. Levine D, Hatabu H, Gaa J, Atkinson MW, Edelman RR Fetal anatomy revealed with fast MR sequences. AJR. 1996;167:905-908.
26. Yamashita Y, Namimoto T, Abe Y, et al. MR imaging of the fetus by a HASTE sequence AJR. 1997;168:513-519.
27. Trop I, Levine D Normal fetal anatomy as visualized with fast magnetic resonance imaging Top Magn Reson Imaging. 2001;12:3-17.
28. Shigeru Y, Ishii K, Sasaki M, et al. Evaluation of standardized uptake value to assess cerebral glucose metabolism. Clin Nucl Med. 2000;25:11-16.
29. Ramos CD, Erdi YE, Gonen M, et al. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. Eur J Nucl Med. 2001;28:155-164.
30. Quraishi AN, Illsley NP. Transport of sugars across human placental membranes measured by light scattering Placenta 1999;20:167-174.
31. Adelstein SJ. Administered radionuclides in pregnancy. Teratology. 1999;59: 236-239.
32. Lamm C, Windischberger C, Leodolter U, Moser E, Bauer H. Co-registration of EEG and MRI data using matching of spline interpolated and MRI-segmented reconstructions of the scalp surface. Brain Topogr. 2001;14:93-100.
33. Bamden L, Kwiatek R, Lau Y, et al. Validation of fully automatic brain SPET to MR co-registration. Eur J Nucl Med. 2000;27:147-154.
34. 15O positron emission tomography applicable to the brain activation study in cats: registration of images of cerebral blood flow to brain atlas Ann Nucl Med 1997;11:315-319.
35. Singh KD, Holliday IE, Furlong PL, Harding GF. Evaluation of MRI-MEG/EEG co-registration strategies using Monte Carlo simulation. Electroencephalogr Clin Neurophysiol. 1997;102:81-85
36. 18FDG positron emission tomography Science 1986;231:840-843.
37. Fowler KA, Huerkamp MJ, Pullium JK, Subramanian T. Anesthetic protocol: propofol use in rhesus macaques (Macaca mulatta) during magnetic resonance imaging with stereotactic head frame application. Brain Res Brain Res Protoc. 2001;7:87-93